Statin use vs. average non-HDL cholesterol levels in Kyrgyzstan
Kyrgyzstan: Statin use vs. average non-HDL cholesterol levels was 3.2 in 2018. ▬ Flat
Statin use vs. average non-HDL cholesterol levels in Kyrgyzstan, 1980–2018
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
Analysis
Kyrgyzstan recorded 3.2 for statin use vs. average non-hdl cholesterol levels in 2018. That is the highest value across all 39 years on record.
That represents a change of up 3.2% over ten years.
Over the whole period, statin use vs. average non-hdl cholesterol levels in Kyrgyzstan peaked at 3.2 in 2014 and was at its lowest, 3.1, in 1980.
Kyrgyzstan ranks 118th of 191 countries on this measure, in the middle of the range.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 3.1 | 3.1 | 3.1 | 10 |
| 1990s | 3.1 | 3.1 | 3.1 | 10 |
| 2000s | 3.1 | 3.1 | 3.1 | 10 |
| 2010s | 3.16 | 3.1 | 3.2 | 9 |
Countries ranked near Kyrgyzstan
- 118 Armenia 3.2 compare
- 118 Australia 3.2 compare
- 118 Belarus 3.2 compare
- 118 Canada 3.2 compare
- 118 Denmark 3.2 compare
- 118 East Timor 3.2 compare
- 118 India 3.2 compare
- 118 Iran 3.2 compare
- 118 Ireland 3.2 compare
- 118 Moldova 3.2 compare
- 118 Nepal 3.2 compare
- 118 Palau 3.2 compare
- 118 Saint Vincent and the Grenadines 3.2 compare
- 118 Tanzania 3.2 compare
- 118 Venezuela 3.2 compare
More reference data data for Kyrgyzstan
- Spring temperature anomalies 1.64 °C (2026)
- Summer temperature anomalies 1.65 °C (2026)
- Temperature anomalies by month 1.94 °C (2026)
- Universal right to vote in practice 2 (2025)
- Autumn temperature anomalies 1.49 °C (2025)
- Winter temperature anomalies 4.2 °C (2025)
- Consumer price index 265.55 2010 = 100 (2025)
- Universal right to vote 2 (2025)
- Competitive elections 0 (2025)
- Men's universal right to vote 1 (2025)
Frequently asked questions
- What is statin use vs. average non-hdl cholesterol levels in Kyrgyzstan?
- Statin use vs. average non-hdl cholesterol levels in Kyrgyzstan was 3.2 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
- What is the highest statin use vs. average non-hdl cholesterol levels recorded in Kyrgyzstan?
- The highest recorded value was 3.2 in 2014.
- What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Kyrgyzstan?
- The lowest recorded value was 3.1 in 1980.
- How does Kyrgyzstan rank for statin use vs. average non-hdl cholesterol levels?
- Kyrgyzstan ranks 118th out of 191 countries with data for 2018.
- Is statin use vs. average non-hdl cholesterol levels rising or falling in Kyrgyzstan?
- Over the last ten years it is up 3.2%. The long-run trend across the full record is flat.
- Where does this Kyrgyzstan data come from?
- The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.